Clare Pelham comments on new sodium valproate regulations
30 April 2018
Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.
Charity tells health secretary new drug regulations could fail without public campaign
24 April 2018
Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in...
Poster campaign raises awareness of epilepsy on public transport
23 April 2018
This week, for the first time ever, epilepsy is featuring as part of a high profile poster campaign across London's underground and bus networks.
Epilepsy Society welcomes new measures to ensure no babies are exposed to sodium valproate during...
23 March 2018
Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women...
Consultation launched on whether tax treatment of charities needs reform
15 March 2018
The Charity Tax Commission has launched a consultation seeking views on whether and how the tax treatment of charities - estimated to be worth around £3.7bn a year -...
Garden shines spotlight on epilepsy at Chelsea Flower Show
13 March 2018
For the first time ever, Epilepsy Society is sponsoring a garden at the RHS Chelsea Flower Show, designed to shine a spotlight on epilepsy and raise awareness of the...
Epilepsy Society praises Government decision to review handling of concerns around sodium valproate
21 February 2018
Epilepsy Society's chief executive Clare Pelham has praised the Government's decision to announce a forward-looking review that will address the way the healthcare...
Me and My Shadow scheme launches on International Women's Day
20 February 2018
Epilepsy Society's new Me and My Shadow scheme is launching to celebrate International Women's Day on 8th March.